Share chart Dr. Reddy's Laboratories
Extended chart
Simple chart
About Dr. Reddy's Laboratories
Dr. Reddy’s (Dr. Reddy’s Laboratories) — международная индийская фармацевтическая компания со штаб-квартирой в Хайдарабаде, вторая по объёмам продаж лекарственных средств в Индии (2015, после Sun Farmaceuticals). Выпускает как дженерики (Цетрин, Экзифин), так и патентованные препараты (Ибуклин, Декспан Плюс, Кеторол-гель), также оказывает фармацевтические услуги, производит фармсубстанции. Основана в 1984 году доктором Анджи Редди (англ. Anji Reddy). Кроме национального, работает на международных рынках, в основном — в развивающихся странах. more detailsMain settings
IPO date
2001-04-11
ISIN
US2561352038
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
inr
Див.доход ао
0.5804
Дивиденд ао
0.575
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 3.66 | 5 |
| P/BV | 3.64 | 5 |
| P/E | 18.33 | 7 |
Efficiency
| Title | Value | Grade |
| ROA | 15.68 | 5 |
| ROE | 21.69 | 7 |
| ROIC | 20.99 | 7 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0.6138 | 1.53 |
| DSI | 0.9286 | 9.29 |
| Average dividend growth | -1.41 | 0 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 0.2264 | 10 |
| Debt/Ratio | 0.0517 | 10 |
| Debt/Equity | 0.0714 | 10 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 59.89 | 7 |
| Yield Ebitda, % | 78.53 | 8 |
| Yield EPS, % | 2320.45 | 10 |
Dividends
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 16.17 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| Week | 15.55 $ | 15.63 $ | 16.17 $ | 3.99 % | 0 % | 0 % |
| Month | 14.28 $ | 14.28 $ | 16.17 $ | 13.24 % | 0 % | 0 % |
| Three month | 13.02 $ | 12.36 $ | 16.17 $ | 24.19 % | 0 % | 0 % |
| Half a year | 13.84 $ | 12.36 $ | 16.17 $ | 16.84 % | 0 % | 0 % |
| Year | 16.64 $ | 12.36 $ | 83.47 $ | -2.85 % | 0 % | 0 % |
| 3 years | 51.6 $ | 12.36 $ | 83.47 $ | -68.66 % | 0 % | 0 % |
| 5 years | 70.95 $ | 12.36 $ | 83.47 $ | -77.21 % | 0 % | 0 % |
| 10 years | 47.52 $ | 12.36 $ | 83.47 $ | -65.97 % | 0 % | 0 % |
| Year to date | 13.6 $ | 12.36 $ | 16.17 $ | 18.9 % | 0 % | 0 % |
Main owners
Contained in ETF
| ETF | Share, % | Profitability for 1 year, % | Commission, % |
| First Trust Chindia ETF | 3.46 | 12.74 | 0.59 |
| First Trust BICK Index Fund | 2.62 | 21.62 | 0.64 |
| 3.04 | 17.18 | 0.61 |
|---|
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Gunupati Venkateswara Prasad B.E. | Co-Chairman, MD & Member of Management Council | 2.25M | 1960 (65 years) |
| Mr. Erez Israeli M.B.A. | CEO & Member of the Management Council | N/A | 1968 (57 years) |
| Mr. Deepak Sapra M.B.A. | CEO of API & Services & Member of Management Council | N/A | 1975 (50 years) |
| Ms. Archana Bhaskar B.Sc., M.B.A. | EVP, Head of Corporate Communications, Chief Human Resources Officer & Member of Management Council | N/A | 1967 (58 years) |
| Mr. Sanjay Sharma B.Tech. | Executive VP, Global Head of Global Manufacturing & Member of Management Council | N/A | 1968 (57 years) |
| Mr. Patrick Aghanian B.A., M.B.A. | CEO of European Generics & Member of Management Council | N/A | 1965 (60 years) |
| Mr. Kallam Satish Reddy B.Tech., M.S. | Chairman of the Board & Member of the Management Council | 1.38M | 1967 (58 years) |
| Mr. Venkata Ramana Motupalli M.B.A. | CEO of Branded Markets - India & Emerging Countries and Member of Management Council | N/A | 1969 (56 years) |
| Mr. Mannam Venkatanarasimham | CFO & Member of the Management Council | ||
| Mr. Krishna K. Venkatesh B.Pharma M.S. | Global Head of Quality and Pharmacovigilance & Member of the Management Council | 1973 (52 years) |
About company
Address: India, Hyderabad, 8-2-337 Road No. 3 - Open in google maps, Open in yandex maps
Website: https://www.drreddys.com
Website: https://www.drreddys.com
